Global psychedelic drugs market is rising gradually with a healthy CAGR in the forecast period of 2019-2026. Growing prevalence of depression worldwide and increase in special designation from the regulatory authorities to the company to expedite the development process are the key factors for market growth.
Few of the major competitors currently working in the global psychedelic drugs market are COMPASS, The Emmes Company, LLC, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V. , Merck & Co., Inc, Alkermes, ALLERGAN, H. Lundbeck A/S among others.
Get Exclusive Sample Copy of This Report Here
A systematic, objective and exhaustive study of the details related to several subjects in the field of marketing have been conducted to produce this Psychedelic Drugs market research report. This market report genuinely analyses the potential of the market with respect to current scenario and the future prospects by taking into consideration numerous industry aspects. Not to mention, various steps for gathering, analysing and recording the data and information have been utilized for generating the report. Businesses can confidently refer this top-quality Psychedelic Drugs market report to accomplish an absolute success. The market drivers and restraints have been explained in the document using SWOT analysis.
Psychedelic drugs are also known as psychedelics are the class of hallucinogenic drugs including both classic hallucinogens as well as dissociative drugs that are used recreationally, to alter and enhance the sensory perception, elevate the mood swings, thought process, energy level promoting spiritual experiences. Psychedelic drugs have been used experimentally for psychological treatment and are able to control mind hence maintaining peace.
According to the statistic published in our World in Data 2017, the global burden of mental and substance use disorders were 122.76 million. Increase cases of mental disorders and accelerating demand of novel therapies are the drivers promoting the growth of this market.
Segmentation: Global Psychedelic Drugs Market
Psychedelic Drugs Market : By Application
- Major Depressive Disorder
- Resistant depression
- Panic disorder
- Post-traumatic stress disorder
- Opiate Addiction
- Others
Psychedelic Drugs Market : By Drugs
- Lysergic Acid Diethylamide (LSD)
- 3,4-MethylEnedioxyMethamphetamine (Ecstasy)
- Phencyclidine
- Gamma Hydroxybutyric Acid (GHB)
- Ketamine
- Ayahuasca
- Salvia
- Psilocybin
- Others
Psychedelic Drugs Market : By Route of Administration
- Oral
- Injectable
- Inhalation
Psychedelic Drugs Market : By Distribution Channel
- Direct Retailers
- Online Pharmacies
- Others
Psychedelic Drugs Market : By End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Psychedelic Drugs Market : By Geography
- North America
- South America
- Europe
- Asia-Pacific
- Middle East & Africa
Read Complete Details with TOC Here
Key Developments in the Psychedelic Drugs Market:
- In October 2018, COMPASS received Breakthrough Therapy designation from the FDA for psilocybin therapy for the treatment of resistant depression. With Breakthrough Therapy designation, company can obtain all fast track designation features and FDA commitment and guidance ensuring efficient drug development programme
- In August 2018, COMPASS received new drug application approval from the FDA for the psilocybin therapy for the treatment of resistant depression. If the trial is successful, it will change the treatment landscape of patients suffering from resistant depression
Primary Respondents : Psychedelic Drugs Market
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Report potential : Psychedelic Drugs Market
- Detailed overview of parent market
- Changing market dynamics of the industry
- Strategies of key players and product offerings
- In-depth market segmentation
- To gain insightful analyses of the market and have a comprehensive understanding of the “Psychedelic Drugs” and its commercial landscape
- Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the Psychedelic Drugs market
To Get This Report at an Attractive Cost, Click Here
About Data Bridge Market Research:
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.
Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: [email protected]
https://databridgemarketresearch.com